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Abstract
Background Intraoperative microelectrode recording (MER)
for targeting during deep brain stimulation (DBS) procedures
has been evaluated over a period of 4 years, in 57 consecutive
patients with Parkinson’s disease, who received DBS in the
subthalamic nucleus (STN-DBS), and 28 consecutive patients
with either dystonia (23) or Parkinson’s disease (five), in
whom the internal segment of the globus pallidus (GPi-DBS)
was targeted.
Methods The procedure for DBS was a one-stage bilateral
stereotactic approach using a combined electrode for both
MER and macrostimulation. Up to five micro/macro-
electrodes were used in an array with a central, lateral,
medial, anterior, and posterior position. Final target location
was based on intraoperative test stimulation.
Findings For the STN, the central trajectory was chosen for
implantation in 50% of the cases and for the globus pallidus
internus (GPi) in 57% of the cases. Furthermore, in 64% of
the cases, the channel selected for the permanent electrode
corresponded with the trajectory having the longest
segment of STN MER activity. For the GPi, this was the
case in 61%. The mean and standard deviation of the
deepest contact point with respect to the magnetic reso-
nance imaging (MRI)-based target for the STN was 2.1±
1.5 mm and for the GPi was −0.5±1.2 mm.
Conclusions MER facilitates the selection of the final
electrode location in STN-DBS and GPi-DBS, and based
on the observed MER activity, a pre-selection could be
made as to which channel would be the best candidate for
macro-test stimulation and at which depth should be
stimulated. The choice of the final location is based on
intraoperative test stimulation, and it is demonstrated that
regularly it is not the central channel that is chosen for
implantation. On average, the target as defined by MER
activity intensity was in accordance with the MRI-based
targets both for the STN and GPi. However, the position of
the best MER activity did not necessarily correlate with the
locus that produced the most beneficial clinical response on
macroelectrode testing intraoperatively.
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Introduction
Intra-operative microelectrode recording (MER) has been
introduced to improve the target localization during
stereotactic surgery [4, 21, 24]. Benabid developed a holder
with five parallel channels for micro/macro needles [2, 3].
The needle for MER, which is incorporated in the electrode
for test stimulation, is able to pick up electrical activity of
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individual neurons close to the electrode due to its small tip.
Spike patterns for neurons situated either in the subthalamic
nucleus (STN) or in the globus pallidus (GP) are charac-
teristic, and they differ from neuronal spike patterns of the
surrounding structures. This creates the possibility to
demarcate the borders of both target structures [17–21, 23,
27, 30, 38–40]. Furthermore, inside the STN and the GP, a
variety of neurons, laminae, and substructures can be
recognized that demarcate functionally different areas [13,
14, 22, 25, 26, 31–33, 35, 37].
Although MER reveals the electrical activity and
patterns of different brain (sub)structures, it is difficult to
determine whether MER has a positive effect on the clinical
outcome of deep brain stimulation (DBS) treatment [15,
16]. Ultimately, it would be important to know whether the
use of MER has a positive effect on clinical outcome and
whether the influence that MER has had on the choice of
the target has been beneficial. These questions, however,
are very difficult to answer since the clinical outcome is
determined by many more factors than the use of MER
alone. Therefore, this has not been the aim of the current
study. As a first result of this longitudinal study on MER
during DBS, it was investigated to what extent the use of
MER influences the DBS surgical procedure. The relative
contribution of the physiological data obtained by MER
and the clinical data obtained by intraoperative test
stimulation to the selection of the final position for
implantation was evaluated. Furthermore, we examined to
what extent the activity pattern obtained from the MER
corresponded with the target position based solely on three-
dimensional magnetic resonance imaging (3D-MRI). Finally, it
was studied whether the target position based on the best MER
activity matched the finally chosen location for electrode
implantation based on intraoperative test stimulation.
Methods
Patients
Over a period of 4 years, 57 consecutive patients with
Parkinson’s disease (PD) who received DBS in the
subthalamic nucleus (STN-DBS) and 28 consecutive
patients with either dystonia (n=23) or Parkinson’s disease
(n=5) in whom the internal segment of the globus pallidus
(GPi-DBS) was targeted were included. Data of two STN
patients could not be used since, in one patient with
bilateral implant, only activity from the central channel was
recorded, and in another patient, a large external electrical
artifact was present. In 12 patients, surgery was performed
unilaterally. This makes a total of 98 STN sides. Data of
three globus pallidus internus (GPi) patients could not be
used since, in one patient, only activity from the central
channel was recorded, one patient was operated on with
anesthesia, and in the recordings of the third patient, a large
external electrical artifact was present. In four patients,
surgery was performed unilaterally. This makes a total of 46
insertions in the GPi. All the patients gave informed
consent for the surgical DBS procedure including MER.
Some of the patients with Parkinson’s disease included in
this study were randomized to STN or GPi-DBS as part of a
large multicenter clinical trial. Inclusion criteria for surgery
(idiopathic Parkinson’s disease with invalidating motor
fluctuations) and exclusion criteria (psychosis, severe
depression, dementia, general contraindications for surgery)
were the same for patients allocated to STN-DBS or GPi-
DBS, and for patients not participating in the trial. All
patients who were included in the study received surgery
under local anesthesia.
Surgery
The procedure for DBS was a one-stage bilateral stereo-
tactic approach, using frame-based 3D-MRI reconstruc-
tions for target calculations and path-planning, with MER
and macro-test stimulation. The standard target coordi-
nates used were 12 mm lateral to the midplane of the third
ventricle, 2 mm posterior to the midcommissural point
(MCP), and 4 mm below the intercommissural line (ICL)
for the STN, and 21 mm lateral to the midplane, 2 mm
anterior to the MCP, and 5 mm below the ICL for the GPi.
Adjustments were made based on visual anatomy on the
planning MRI if necessary. The paths for the central
channel were defined using the following criteria: anterior
angulation to ICL of 15–20°, lateral angulation from
midline 20–30°, entry on top of a gyrus, and avoiding
sulci, cortical surface veins, and the lateral ventricles. In
bilateral cases, surgery started on the left side. Three to
five steel cannulas and microelectrodes were inserted
through a 12-mm diameter precoronal burr hole. All steel
cannulas stayed in place throughout the surgical procedure
to prevent brain displacement during surgery and to
prevent choosing the wrong tract during final electrode
implantation. The implanted electrodes were model 3389
(Medtronic, Minneapolis, MN, USA) with four platinum–
iridium cylindrical surfaces (1.3 mm diameter and 1.5 mm
length) and with an intercontact separation of 0.5 mm.
Contact 0 was the most distal, and contact 3 was the
most proximal. All patients included in this study were
awake during the surgical procedure, and none of them
were under sedatives. In PD patients, surgery and MER
were performed following overnight withdrawal of anti-
parkinsonian medication. To verify electrode position,
patients underwent postoperative frame-based stereotactic
X-ray or postoperative frame-based stereotactic computed
tomography (CT).
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Microelectrode recording
To perform MER in STN-DBS, five MER/macrostimulation
needles were placed in an array with a central, lateral, medial,
posterior, and an anterior position placed 2 mm apart, to
delineate the borders of the nucleus. Depending on the pre-
operative MRI, it was decided in some cases to record with
three or four microelectrodes rather than five. In GPi-DBS,
based on the pre-operative MRI and the better visibility of the
GP structures and internal capsule, usually three to four
channel recordings were performed in the central, medial,
posterior, and lateral channel to define the distance of the
calculated target to the border between GPi and the internal
capsule. The anterior channel was included rarely.
Extracellular single/multi-unit MER was performed with
small (10 μm width) polyamide-coated tungsten micro-
electrodes (Medtronic; microelectrode 291; impedance
1.1±0.4 MΩ; measured at 220 Hz, at the beginning of
each trajectory) mounted on a sliding cannula. Signals were
recorded with the amplifiers (10,000 times amplification) of
the Leadpoint system (Medtronic), using a bootstrapping
principle and were analog bandpass filtered between 500
and 5,000 Hz (−3 dB; 12 dB/oct). The signal was sampled
at 12 kHz, by use of a 16-bit A⁄D converter and afterwards
up-sampled to 24 kHz off-line. Following a 2-s signal
stabilization period after electrode movement cessation,
multi-unit segments were recorded for 5–20 s.
Starting for STN and GPi, respectively, 8 and 12 mm
above the MRI-based target, the microelectrodes were
advanced in steps of 500 μm towards the target by a
manual microdrive. When the needles were inside the STN,
GPe (globus pallidus externus) and GPi at each depth, the
spiking activity of the neurons lying close to the needle
(pick-up area up till 200 μm) could be recorded. Depending
on the neuronal density not more than 3–5 units were
recorded simultaneously. More distant units could not be
distinguished from the background level.
Positioning of DBS targets from MER
The STN was clearly distinguished from the dorsally located
zona incerta and lenticular fasciculus (field H2) by a sudden
increase in background noise level and increase in discharge
rate typically characterized by rhythmic bursts of activity with a
burst frequency between 5 to 20 Hz [7]. Deeper into the STN
rhythmic burst activity shifted to higher frequencies lying
between 15 to 40 Hz. Also, more irregular firing units were
observed. The ventral border of the STN was recognized by a
decrease of background noise and a decrease of multi-unit
activity across a distance of 0.5 to 2 mm, and, passing the
ventral border of the STN, a sharp decrease in background
firing was found, with more regular firing units (mean fire
frequency 20 to 80 Hz) of the substantia nigra (Fig. 1).
The GPe could be delineated from the dorsally located
putamen by an increase in multi-unit firing activity at a depth
varying from −12 to −9 mm from the MRI-based target. At
advancing depth between −7 to −5 mm, the medial medullary
lamina separating the GPe from the GPi was reached. The
presence of this lamina was characterized by a decrease in
electrical activity and had a thickness of 1 to 2 mm. In the
vicinity of the medial medullary lamina, border cells were
often recorded with a tonic regular discharge frequency
between 5 to 30 Hz. The GPi was usually more densely
packed with neurons reflected by a more intense multi-unit
activity than observed in the GPe. Also, bursting and pausing
activity (dystonia) and tremor-related (in PD) activity were
frequently observed in the GPi. Within the GPi, regularly,
another lamina at about −2 mm could be observed. The
bottom of the GPi was recognized by a sudden decrease in
background noise and multi-unit activity as the optic tract was
approached (Fig. 2). Data segments were analyzed off-line
for stability by visual inspection. When instability or
movement/vibration or electrical artifacts were observed,
the longest stable section was selected from the recording,
discarding the rest.
Macro-test stimulation
After MER, the tip of the microelectrode was retracted.
Channels that showed significant multi-unit activity over a
length longer than 3 mm were selected for intraoperative
test stimulation (60 μs pulse-duration; 130 Hz pulse-
frequency). The complete electrode with the macro-tip
was then advanced to be used for macro-test stimulation,
and this was performed by an experienced neurologist at
two or three depths with a 2-mm interval, all within the
boundaries of the target nucleus as determined by MER.
After evaluation of the selected channels by macro-test
stimulation, the one with the largest therapeutic window, i.e.,
lowest current threshold for improvement of symptoms and
highest threshold for side effects, was chosen for permanent
electrode implantation. For dystonic patients, the threshold for
capsular side effects was used to select the best electrode. In
addition, improvement of mobile dystonia was sought when
present.
With respect to depth of implantation of the electrodes in
STN-DBS, it is our custom to implant contact number 1 at
the point with best stimulation parameters, with the deepest
contact 2 mm below this optimal point. For GPi-DBS, we
position the deepest contact point at the inferior border of
the nucleus as determined by MER.
Statistical analysis
In bilateral operated patients, the choice of channel for final
electrode impantation (central versus non-central) from the
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operated side first (left) and second (right) was compared
using the McNemar’s test. Similarly, the implantation depth
of the final electrode was compared with the Student’s t
test. Histograms of distributions and their standard devia-
tions as well as linear regressions were calculated with
Microsoft Excel.
Results
Microelectrode recording
All STN and GPi insertions showed, at least on one
channel, MER activity. However, for the STN in nine out of
Fig. 2 Single/multi-unit activity ofGPi for various depths (−7.5 to 0mm). Note that the negative values correspondwith positions above theMRI-based target.
At −4.5 and −4 mm clearly, the lamina between the external and internal segment of the GP can be observed. The bottom of the GPi is reached at 0 mm
Fig. 1 Single/multi-unit activity of STN for various depths (−2 to +5mm).
Note that the negative values correspond with positions above the target.
The superficial part of the STN (−1 to 0 mm) is clearly recognized by an
increase in background noise and a sudden increase in discharge rate
characterized by rhythmic bursts of activity in this case from 15 to 25 Hz.
Deeper layers of the STN (+1.5 to 3.5 mm) show a more irregular high-
frequency discharge pattern. SN activity (+5 mm) consists of a low-
frequency tonic discharge
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98 cases (9%) and for the GPi in one out of 48 cases (2%),
no MER activity was recorded at the central channel.
Tables 1 (STN) and 2 (GPi) show the frequency
distribution of the final choice for permanent electrode
implantation in the central, lateral, medial, anterior, or
posterior channels based on MER and macro-test stimula-
tion, as well as the distribution of the channels in which the
best MER was observed, i.e., the longest trajectory with
STN or GPi neuronal activity. The central channel was
chosen for implantation of the permanent electrode in 50%
of the STN and in 57% of the GPi cases. In 64% of the
STN cases and in 61% of the GPi cases, the channel with
the best MER activity was also chosen for implantation of
the permanent electrode. In case the central electrode was
selected for implantation of the electrode, this was also the
channel with best MER in 78% for STN and in 76% for
GPi. The final electrode position in the STN, if not placed
in the central channel, was more often lateral than medial to
the calculated target [10% (10/98) lateral; 6% (6/98)
medial] and more often anterior [24% (22/98)] than
posterior [(10% (10/98)]. Best MER activity for the STN
was also found more lateral than medial and more anterior
than posterior from the calculated target. The final electrode
position for the GPi had the tendency to go more laterally
than medially. Although in the GPi, MER activity was
highest at the posterior electrode in 20% (9/46) of the cases,
due to side effects with macro-test stimulation in only two
of nine instances, this channel was selected for permanent
stimulation. The anterior channel was rarely used. In
bilaterally operated STN-DBS patients, the central channel
was chosen for final electrode implantation in 50% of the
left STNs and 39% of the right STNs (p=0.42). In
bilaterally operated GPi-DBS patients, the central channel
was chosen for final electrode implantation in 82% of the
left GPis and 65% of the right GPis (p=0.37).
The final depth of implantation relative to the MRI-based
target in this study is depicted in Fig. 3. For the STN, the
average depth of the deepest contact point for stimulation
electrode was 2.1 mm (SD=1.5 mm) which implies an almost
exact correspondence between the target calculated on the
planning-MRI and the mean optimal position of contact point
1, due to the 2 mm difference between the centers of two
successive contact points. For the GPi, the deepest contact
point was implanted on average almost at the calculated depth
(mean=−0.5 mm; SD=1.2 mm, Fig. 3b) In summary, this
implied that, in 56 out of 98 (57%) of the STN implantations
and in 39 out of 46 (85%) of the GPi-implantations, the final
depth of implantation was situated within a range of ±1 mm
of the MRI-based target depth. In bilaterally operated STN-
DBS patients, mean implantation depth for the final electrode
was 2.3 mm below calculated target depth for the left STN
and 2.6 mm for the right STN (p=0.23). In bilaterally
operated GPi-DBS patients, mean implantation depth for the
final electrode was 0.71 mm above calculated target depth for
the left GPi and 0.88 mm for the right GPi.
Table 1 Comparison between the channel with the best MER activity
and the channel finally chosen for permanent stimulation in the STN
Results STN Right (n=47) Left (n=51) Total (n=98)
Final electrode
Central 47% (22) 55% (28) 50%
Medial 8.5% (4) 4% (2) 6%
Lateral 15% (7) 6% (3) 10%
Anterior 25.5% (12) 20% (10) 24%
Posterior 4% (2) 15% (8) 10%
Best electrode
Central 47% (22) 47% (24) 47%
Medial 13% (6) 4% (2) 8%
Lateral 23% (11) 16% (8) 20%
Anterior 13% (6) 20% (10) 16%
Posterior 4% (2) 13% (7) 9%
Final = best
Central 77% (17/22) 79% (19/24) 78% (36/46)
Medial 67% (4/6) 0% (0/2) 50% (4/8)
Lateral 36% (4/11) 25% (2/8) 32% (6/19)
Anterior 100% (6/6) 70% (7/10) 81% (13/16)
Posterior 50% (1/2) 57% (4/7) 55% (5/9)
Total 66% (31/47) 63% (32/51) 64% (63/98)
Table 2 Comparison between the channel with the best MER activity
and the channel finally chosen for permanent stimulation in the GPi
Results GPi Right (n=24) Left (n=22) Total (n=46)
Final electrode
Central 50% (12) 64% (14) 57%
Medial 8% (2) 18% (4) 13%
Lateral 34% (8) 9% (2) 22%
Anterior 4% (1) 0% (0) 2%
Posterior 4% (1) 9% (2) 6%
Best electrode
Central 54% (13) 54% (12) 54%
Medial 12.5% (3) 18% (4) 15%
Lateral 12.5% (3) 9% (2) 11%
Anterior 0% (0) 0% (0) 0%
Posterior 21% (5) 18% (4) 20%
Final/best
Central 85% (11/13) 67% (8/12) 76% (19/25)
Medial 33% (1/3) 50% (2/4) 43% (3/7)
Lateral 100% (3/3) 50% (1/2) 80% (4/5)
Anterior 0% (0/0) 0% (0/0) 0% (0/0)
Posterior 20% (1/5) 25% (1/4) 22% (2/9)
Total 67% (16/24) 54% (12/22) 61% (28/46)
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The depth position of the STN-middle with respect to the
MRI-based target was calculated from the beginning and
end of the STN MER activity of the channel that had the
best MER activity. The mean value of the distribution was
0.0 mm with an SD of 1.6 mm (Fig. 4a). Combined with
the results shown in Fig. 3a, this meant that, on average,
contact point 1 was placed in the middle of the STN. From
the distribution, it also followed that 27% of the STN-
middles fell outside ±1.5 mm, and only 7% fell outside the
range of ±3.0 mm. Figure 4b shows the comparison
between the STN-middle and the final depth implantation
of the deepest contact point relative to the MRI-based
target, and it is demonstrated that there is a larger range
(±4 mm) for the position of the STN-middle than for the
finally chosen depth (−1 to +5). A linear regression through
these data for both left and right STN implantations crosses
the vertical axis at about 1.9 and 2.4 mm, respectively. This
is due to the fact that the deepest contact point is always
situated one contact point (2 mm) below the optimal
position.
Complications from surgery
One patient undergoing STN-DBS postoperatively had a left-
sided hemiparesis due to a right-sided subcortical hematoma.
The hemiparesis completely resolved in the year following
surgery. Another patient undergoing STN-DBS had a general-
ized seizure on postoperative day 1. CT showed bilateral
subdural air, but no bleeding. No other complications were
noted in the clinical records of the rest of the patients. Since we
verified electrode position with postoperative frame-based
stereotactic X-ray or postoperative frame-based stereotactic
CT, postoperative brain imaging of not all patients is available.
Approximately half of the STN-DBS and GPi-DBS patients
underwent postoperative frame-based stereotactic CT. These
CTs showed variable amounts of subdural air, but no bleeding.
For the remaining STN-DBS and GPi-DBS patients, who only
underwent postoperative frame-based stereotactic X-ray, any
subclinical bleeding has remained unnoticed. The postoperative
course in this last patient group was uneventful.
Discussion
The current study demonstrates that the finally chosen
depth for STN-DBS coincided in 57% of the cases with the
pre-operatively MRI-based target within a range of ±1 mm.
For GPi-DBS, this was higher and coincided in about 85%
of the cases. These percentages are higher than those found
by Altermann et al. and [1] Molinuevo et al. [27]. The
choice of the final target and which electrode position
yielded the optimum therapeutic window was guided by the
MER activity and finally determined by the results of
intraoperative test stimulation. Standard deviations for the
final depth of the implantations were 1.5 mm for the STN
and 1.2 mm for the GPi, and these were somewhat less than
found in the GPi by Guridi et al. [11] and comparable to
those found by Priori et al. [30].
The position of the STN-middle with respect to the MRI-
based target yielded a normal distribution with an SD of
1.6 mm, which is almost equal to the SD of the depth of the
implanted electrode (1.5 mm). Thus, this variance may
reflect to a certain extend the accuracy of MRI imaging and
also seems reasonable taking into account the MRI slice
thickness of 1 mm [12, 30]. With respect to the required
depth of the permanent electrode, Fig. 4a shows that the
mean value of the calculated STN-middle derived from the
intraoperatively recorded MER activity is in good agree-
ment with the pre-operatively calculated depth of the target
nucleus using MRI-based planning with the Schaltenbrand–
Wahren atlas target coordinates [10, 34]. In case contact
point 1 is placed at a depth that is only given by the MRI-
Fig. 3 a STN frequency distribution of final depth of the deepest
contact point (mean=2.1 mm; SD=1.5 mm) with respect to the MRI-
based target. Intended coordinates: 12 mm lateral to midplane; 2 mm
posterior to MCP; 4 mm inferior ICL. b GPi frequency distribution of
final depth of the deepest contact point (mean=−0.5 mm; SD=1.2 mm)
with respect to the MRI-based target. Intended coordinates: 21 mm
lateral to midplane; 2 mm anterior to MCP; 5 mm inferior to ICL
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based target, due to the variance in the depth of the STN,
not all contact points will be necessarily situated inside the
STN and, therefore, not the best functional target will be
stimulated [8, 13, 23, 28, 32, 33]. The implantable electrode
consists of four contact points with a separation of 2 mm
between the centers of two successive contact points, thus,
according Fig. 4a, in about 85% of the cases, at least two
contact points would lie inside the STN, if only the MRI-
based target should have been used.
The SD of the depth of the implanted electrode in the GPi of
1.2 mmwas somewhat less than the one of 1.5 mm in the STN.
This may be due to the fact that the MRI-based GPi target can
be better determined than the MRI-based STN target. The SD
of the GPi target in the current study is somewhat less than
found by others [12, 27] and the SD of the STN target
comparable to those found by Priori et al. [30].
Based on the observed MER activity in multiple channels, a
pre-selection could be made as to which channel would be the
best candidate for macro-test stimulation and at which depth
should be stimulated [29]. After MER and macro-test
stimulation, in 50% of the cases for the STN and in 57%
for the GPi, the central channel was chosen for electrode
implantation. The percentage of 50% for the STN could have
been even smaller if all insertions were measured with five
channels. Thus, considering the results of Temel et al. [36], in
which a percentage of 34% for left and right STN was found,
our study confirms that, for STN, it is often deviated from the
central channel for implantation. Furthermore, it was found
that, whereas other channels showed STN MER activity, in
9% (9/98), the central channel did not show MER activity.
The final position of the STN target in the axial plane
corresponded in 64% of the cases with the STN target having
the best MER activity and for the GPi target, this was so in
61% of the cases.
For MER and macro-test stimulation, some extra time
was needed to attach the microdrive for the microelectr-
odes, connect the wires to the needles, and check for
integrity of the system and stability of the signals. For STN
and GPi, MER was started 8 and 12 mm above the
calculated target depth, respectively. This resulted in about
25 recordings of 10 s each per site, which took about a
period of 10 min. Then, a summary of recordings was
evaluated in order to decide in which channels and at what
depths test stimulation should be performed. In comparison
to the DBS procedure without MER, the time needed for
the test procedure was thereafter reduced significantly, as
stimulation was only started in two or three channels that
had sufficient MER activity. In addition, if during macro-
test stimulation one of the channels yielded worse results
than others, testing on this particular channel was discon-
tinued. Considering the accuracy of the MRI-based target,
the period of MER could be shortened by starting recording
at 6-mm instead of 8-mm distance from the MRI-based
STN target and 100-mm instead of 12-mm distance from
the MRI-based ventral border of the GPi.
In bilaterally operated patients, we noted a non-significant
trend towards a less frequent choice for the central channel on
the side operated second (right). Significance possibly would
have been reached with a larger patient population. This
possible less accurate coincidence between MRI planning and
MER registration on the second operative side may be due to
cerebral fluid (CSF) loss and subsequent subdural air invasion
during surgery in some cases, potentially causing brain
displacement [9]. Great care, thus, should be taken to
minimize CSF loss, especially when using multiple parallel
microelectrodes that require wider opening of the dura matter
than a single electrode. At the same time, MER provides
direct target recognition and may allow for correction of
stereotactic errors including brain displacement.
Fig. 4 a Frequency distribution of the STN-middle of the MER
activity with respect to the MRI-based STN target. Mean=0.0 mm;
SD=1.5 mm. b Scatter plot of the relationship between the STN-
middle of the MER activity (horizontal) and the final depth of the
deepest contact point (vertical) with respect to the MRI-based STN
target. Data of right and left STN are pooled
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In the current study population, one patient suffered
from a clinically symptomatic hemorrhage (1%). This
raises the question whether the use of multiple trajecto-
ries through the brain in MER could potentially lead to
an increased risk of hemorrhage. Others conclude that
the incremental risk of multiple microelectrode penetra-
tions was small [5], or it was not possible to demonstrate
it given the sample sizes [36]. However, multiple passes
through the brain are likely to be associated with an
increased risk of hemorrhage [6, 15]. Measures can be
taken to reduce this risk, the most important ones being
careful path-planning, avoiding vascular structures, and
the prevention of CSF leakage during the procedure so
that no shearing forces are applied on the brain by the
cannulas due to brain shift. To reduce the risk of
multiple insertions, one could omit one or two channels
for MER. This can be decided on during the MRI
planning. For instance, our study shows that, for the
STN, only in 6% was the medial electrode used for
implantation. With respect to the GPi, the anterior and
the posterior channels were used for implantation in only
2% and 6%, respectively.
Although this study demonstrates that MER improves
targeting, inherent to the setup of this retrospective study,
it is not possible to demonstrate any postoperative
clinical improvement due to the use of MER. However,
if postoperative clinical results are not satisfactory, with
MER registration, inappropriate targeting is the less
probable cause.
In summary, it is concluded from our 4 years experience
that MER facilitates the selection of the final electrode
location in STN-DBS and GPi-DBS and demonstrates that
frequently (about 52%), it is not the central channel that is
chosen. However, in approximately 33% of the STN cases,
the final position of the implanted electrode does not
coincide with the position of optimal MER activity. On the
other hand, for both the STN and GPi, on average, there
is a good fit between the MER activity and the MRI-
based targets with a mean of 0 mm and an SD of
1.5 mm, which means that 95% of the targets fall within
a range of 6 mm.
Finally, it is suggested that, if MER is being used,
probably less than five channels are necessary and MER
could also be started closer than 8 and 12 mm for the MRI-
based STN target and GPi target, respectively.
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